Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Internationally recognised design house Good Earth will participate in Ataya Exhibition 2026, the UAE’s leading women-led philanthropic exhibition, taking place from 12–17 January 2026 at ADNEC, Marina Hall. Held under the patronage of Her Highness Sheikha Fatima bint Mubarak, Ataya brings together women entrepreneurs, designers and purpose-driven brands, with proceeds supporting humanitarian initiatives locally and […] The post GOOD EARTH MARKS A DEFINING MOMENT IN ITS UAE JOURNEY WITH PARTICIPATION IN ATAYA EXHIBITION 2026 appeared first on Web-Release.